Common Stock And Warrant Purchase Agreement Sample Contracts

Pacific Grove Capital LP – MONAKER GROUP, INC. AND THE PURCHASERS NAMED HEREIN COMMON STOCK AND WARRANT PURCHASE AGREEMENT July 31, 2017 MONAKER GROUP, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (January 26th, 2018)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of July 31, 2017 by and between MONAKER GROUP, INC., Nevada corporation with its principal office at 2690 Weston Road, Suite #200, Weston, FL 33331 (the "Company"), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

Cortex Pharmaceuticals – Common Stock and Warrant Purchase Agreement (August 30th, 2017)

This Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this "Agreement"), is entered into by and among RespireRx Pharmaceuticals Inc. (the "Company"), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the "Investors"). This Agreement is expected to be one of several like agreements, collectively the "Common Stock and Warrant Purchase Agreements."

Pacific Grove Capital LP – MONAKER GROUP, INC. AND THE PURCHASERS NAMED HEREIN COMMON STOCK AND WARRANT PURCHASE AGREEMENT July 31, 2017 MONAKER GROUP, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (August 10th, 2017)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of July 31, 2017 by and between MONAKER GROUP, INC., Nevada corporation with its principal office at 2690 Weston Road, Suite #200, Weston, FL 33331 (the "Company"), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

Biocept, Inc. Common Stock and Warrant Purchase Agreement (August 10th, 2017)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of August 9, 2017, by and between Biocept, Inc., a Delaware corporation (the "Company"), and Ally Bridge LB Healthcare Master Fund Limited (the "Purchaser").

Monaker Group, Inc. – MONAKER GROUP, INC. AND THE PURCHASERS NAMED HEREIN COMMON STOCK AND WARRANT PURCHASE AGREEMENT July 31, 2017 MONAKER GROUP, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (August 1st, 2017)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of July 31, 2017 by and between MONAKER GROUP, INC., Nevada corporation with its principal office at 2690 Weston Road, Suite #200, Weston, FL 33331 (the "Company"), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

Monaker Group, Inc. – Addendum to Monaker Group, Inc. Common Stock and Warrant Purchase Agreement (August 1st, 2017)

This Addendum (this "Addendum") is made as of July 31, 2017 to the Common Stock and Warrant Purchase Agreement (the "Agreement") is made as of July 31, 2017 by and between MONAKER GROUP, INC., Nevada corporation with its principal office at 2690 Weston Road, Suite #200, Weston, FL 33331 (the "Company"), and those purchasers listed on the attached Exhibit A of the Agreement, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

Cortex Pharmaceuticals – Common Stock and Warrant Purchase Agreement (March 16th, 2017)

This Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this "Agreement"), is entered into by and among RespireRx Pharmaceuticals Inc. (the "Company"), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the "Investors"). This Agreement is expected to be one of several like agreements, collectively the "Common Stock and Warrant Purchase Agreements."

Cortex Pharmaceuticals – Common Stock and Warrant Purchase Agreement (January 5th, 2017)

This Common Stock and Warrant Purchase Agreement, dated as of [ ], 2016 (this "Agreement"), is entered into by and among RespireRx Pharmaceuticals Inc., (the "Company"), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the "Investors"). This Agreement is expected to be one of several like agreements, collectively the "Common Stock and Warrant Purchase Agreements."

AudioEye – Common Stock and Warrant Purchase Agreement (December 22nd, 2016)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made and entered into as of December 19, 2016, by and among AudioEye, Inc., a Delaware corporation (the "Company"), and the investors set forth on Exhibit A attached hereto (each an "Investor" and collectively, the "Investors").

AudioEye – Common Stock and Warrant Purchase Agreement (April 19th, 2016)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made and entered into as of April 18, 2016, by and among AudioEye, Inc., a Delaware corporation (the "Company"), and the investors set forth on Exhibit A attached hereto (each an "Investor" and collectively, the "Investors").

Cortex Pharmaceuticals – Common Stock and Warrant Purchase Agreement (January 11th, 2016)

This Common Stock and Warrant Purchase Agreement, dated as of [ ], 201[ ] (this "Agreement"), is entered into by and among RespireRx Pharmaceuticals Inc., formerly Cortex Pharmaceuticals, Inc., (the "Company"), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the "Investors"). This Agreement is expected to be one of several like agreements, collectively the "Common Stock and Warrant Purchase Agreements."

Cortex Pharmaceuticals – Second Amended and Restated Common Stock and Warrant Purchase Agreement (August 31st, 2015)

This Common Stock and Warrant Purchase Agreement, dated as of [ ], 2015 (this "Agreement"), is entered into by and among Cortex Pharmaceuticals, Inc. (the "Company"), a corporation incorporated in the state of Delaware, and the undersigned persons and entities listed on the schedule of investors attached hereto as Schedule I (the "Investors"). This Agreement is expected to be one of several like agreements, collectively the "Common Stock and Warrant Purchase Agreements."

Adaptive Medias, Inc. Common Stock and Warrant Purchase Agreement (May 5th, 2015)

This COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of April 30, 2015 between ADAPTIVE MEDIAS, Inc., a Nevada corporation (the "Company"), and James Batmasian (the "Purchaser").

GreenPlex Services, Inc. – Common Stock and Warrant Purchase Agreement (April 13th, 2015)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT is entered into as of this ____ day of April, 2015 (the Agreement), by and among GreenPlex Services, Inc., a Nevada corporation (the Company) and the Purchasers listed on Schedule 1 attached hereto (each a Purchaser and together the Purchasers).

Searchlight Minerals – Common Stock and Warrant Purchase Agreement (March 30th, 2015)

This Common Stock and Warrant Purchase Agreement (this "Agreement"), is made as of March 25, 2015, by and between Searchlight Minerals Corp., a Nevada corporation (the "Company"), and Luxor Capital Partners, LP (the "Investor").

Entia Biosciences, Inc. – Common Stock and Warrant Purchase Agreement Entia Biosciences, Inc. (March 30th, 2015)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT is entered into as of this 15 day of October, 2014 the "Agreement"), by and among Entia Biosciences, Inc., a Nevada corporation (the "Company") and Michael Budagher (the "Purchaser").

Entia Biosciences, Inc. – Common Stock and Warrant Purchase Agreement Entia Biosciences, Inc. (January 5th, 2015)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT is entered into as of the latter of the dates on which this agreement was signed the Agreement), by and among Entia Biosciences, Inc., a Nevada corporation (the Company) and Delta Group Investments Limited (the Purchaser).

Worthington Energy, Inc. – Common Stock and Warrant Purchase Agreement (March 19th, 2013)

This Common Stock and Warrant Unit Purchase Agreement (the "Agreement") is made as of February 13, among Worthington Energy, Inc., a Nevada corporation (the "Company") and Aaron Shrira (the "Investor").

Worthington Energy, Inc. – Worthington Energy, Inc. Common Stock and Warrant Purchase Agreement (March 19th, 2013)

This Common Stock and Warrant Unit Purchase Agreement (the "Agreement") is made as of February 25, among Worthington Energy, Inc., a Nevada corporation (the "Company") and Alan Kau (the "Investor").

Coupon Express Inc. – Common Stock and Warrant Purchase Agreement (January 3rd, 2013)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of the 28th day of December, 2012 by and among COUPON EXPRESS, INC., a Nevada corporation (the "Company"), and FUTURE FARM TRUST, a trust organized under the laws of Michigan with its principal address at 11304 Marquette Drive, New Buffalo MI 49117 (the "Purchaser").

Mannkind Corporation Common Stock and Warrant Purchase Agreement (October 19th, 2012)

This COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this Agreement) is made as of the 18th day of October, 2012 by and between MannKind Corporation, a Delaware corporation (the Company), and The Mann Group LLC (such Purchaser, including its successors and assigns, the Purchaser).

Research Frontiers Incorporated – Research Frontiers Incorporated Common Stock and Warrant Purchase Agreement (October 5th, 2012)

This Common Stock and Warrant Purchase Agreement (this Agreement) is made as of October 2, 2012 by and between Research Frontiers Incorporated, a Delaware corporation (the Company), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a Purchaser, and collectively, the Purchasers).

Magnegas Corporation Common Stock and Warrant Purchase Agreement (April 3rd, 2012)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of March 28, 2012 by and between MAGNEGAS CORPORATION, a Delaware corporation with its principal office at 150 Rainville Road, Tarpon Springs, Florida 34689 (the "Company"), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

Mimvi, Inc. Common Stock and Warrant Purchase Agreement (March 15th, 2012)

This COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is made as of the ___ day of ______, 20___, between MIMVI, Inc., a Nevada corporation (the "Company"), and ____________________ (the "Purchaser").

WILLIAM LYON HOMES CLASS B COMMON STOCK AND WARRANT PURCHASE AGREEMENT February 25, 2012 (March 6th, 2012)

This CLASS B COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this Agreement) is made and entered into as of February 25, 2012, by and between WILLIAM LYON HOMES, a Delaware corporation (the Company) and the person set forth on Schedule 1 hereto (the Purchaser).

PAVANA POWER Corp – Pavana Power Associates Inc. Common Stock and Warrant Purchase Agreement (December 7th, 2011)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is entered into as of March 31, 2010, by and between PAVANA POWER ASSOCIATES INC. (the "Company"), and the party identified as purchaser on the signature pages of this Agreement (the "Purchaser").

Magnegas Corporation and the Purchasers Named Herein Common Stock and Warrant Purchase Agreement (October 28th, 2011)

This Common Stock and Warrant Purchase Agreement (this "Agreement") is made as of _____________, 2011 by and between MAGNEGAS CORPORATION, a Delaware corporation with its principal office at 150 Rainville Road, Tarpon Springs, Florida 34689 (the "Company"), and those purchasers listed on the attached Exhibit A, as such exhibit may be amended from time to time (each a "Purchaser", and collectively, the "Purchasers").

PAVANA POWER Corp – Pavana Power Associates Inc. Common Stock and Warrant Purchase Agreement (October 25th, 2011)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this "Agreement") is entered into as of March 31, 2010, by and between PAVANA POWER ASSOCIATES INC. (the "Company"), and the party identified as purchaser on the signature pages of this Agreement (the "Purchaser").

Mti Microfuel Cells Inc. Amendment No. 2 to Common Stock and Warrant Purchase Agreement (September 28th, 2011)

This Amendment No. 2 to Common Stock and Warrant Purchase Agreement (this "Amendment") is made as of September 23, 2011 (the "Effective Date") by and among MTI MicroFuel Cells Inc., a Delaware corporation (the "Company") and Counter Point Ventures Fund II, LP (the "Purchaser"), and amends that certain Common Stock and Warrant Purchase Agreement, dated as of January 11, 2010, as amended February 9, 2011 (the "Purchase Agreement") between the Company and the Purchaser.

Mti Microfuel Cells Inc. Amendment No. 1 to Common Stock and Warrant Purchase Agreement (February 11th, 2011)

This Amendment No. 1 to Common Stock and Warrant Purchase Agreement (this "Amendment") is made as of February 9, 2011 (the "Effective Date") by and among MTI MicroFuel Cells Inc., a Delaware corporation (the "Company") and Counter Point Ventures Fund II, LP (the "Purchaser"), and amends that certain Common Stock and Warrant Purchase Agreement, dated as of January 11, 2010 (the "Purchase Agreement") between the Company and the Purchaser.

Evergreen Energy – Common Stock and Warrant Purchase Agreement Dated as of March 28, 2002, as Amended (The "Purchase Agreement") (February 3rd, 2011)

Reference is made to the Purchase Agreement and the common stock purchase warrants issued pursuant thereto and currently outstanding as listed on Exhibit A attached to this letter (the "Warrants").

Evergreen Energy – Common Stock and Warrant Purchase Agreement Dated as of March 28, 2002, as Amended (The "Purchase Agreement") (January 3rd, 2011)

Reference is made to the Purchase Agreement and the common stock purchase warrants issued pursuant thereto and currently outstanding as listed on Exhibit A attached to this letter (the "Warrants").

Entia Biosciences, Inc. – Common Stock and Warrant Purchase Agreement Total Nutraceutical Solutions, Inc. (December 20th, 2010)

THIS COMMON STOCK AND WARRANT PURCHASE AGREEMENT is entered into as of this ____ day of ________, 2010 the Agreement), by and among Total Nutraceutical Solutions, Inc., a Nevada corporation (the Company) and the Purchasers listed on Schedule 1 attached hereto (each a Purchaser and together the Purchasers).

Entia Biosciences, Inc. – [APPENDIX a to the Common Stock and Warrant Purchase Agreement] FORM OF a WARRANT (December 20th, 2010)

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE LAWS, AND NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY S UCH TRANSACTION, OR SUCH TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND LAWS, SUCH COMPLIANCE, AT THE OPTION OF THE CORPORATION, TO BE EVIDENCED BY AN OPINION OF THE WARRANT HOLDER'S COUNSEL, IN FORM ACCEPTABLE TO THE CORPORATION, THAT NO VIOLATION OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM ANY PROPOSED TRANSFER OR ASSIGNMENT.

Entia Biosciences, Inc. – [APPENDIX B to the Common Stock and Warrant Purchase Agreement] FORM OF B WARRANT (December 20th, 2010)

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE LAWS, AND NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRA NSACTION, OR SUCH TRANSACTION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND LAWS, SUCH COMPLIANCE, AT THE OPTION OF THE CORPORATION, TO BE EVIDENCED BY AN OPINION OF THE WARRANT HOLDER'S COUNSEL, IN FORM ACCEPTABLE TO THE CORPORATION, THAT NO VIOLATION OF SUCH REGISTRATION PROVISIONS WOULD RESULT FROM ANY PROPOSED TRANSFER OR ASSIGNMENT.